Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-15 Purchase | 2025-12-16 09:30 am | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 27,500 | $4.12 | $113,300 | 2,498,000 (Direct) | View |
| 2025-11-05 Purchase | 2025-11-06 07:30 am | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 272,500 | $2.2 | $599,500 | 1,272,500 (Direct) | View |
| 2025-08-26 Purchase | 2025-08-28 4:56 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 265,976 | $0.66959 | $178,095 | 1,000,000 (Direct) | View |
| 2025-05-16 Purchase | 2025-05-20 6:01 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 350,000 | $0.49918 | $174,713 | 734,024 (Direct) | View |
| 2024-09-09 Purchase | 2024-09-11 5:47 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 140,000 | $2.8222 | $395,115 | 384,024 (Direct) | View |
| 2024-01-29 Purchase | 2024-01-31 6:29 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 100,000 | $3.8674 | $386,738 | 244,024 (Direct) | View |
| 2022-12-08 Purchase | 2022-12-12 8:00 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 55,250 | $2.096 | $115,804 | 144,024 (Direct) | View |
| 2022-06-30 Sale | 2022-07-05 4:30 pm | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $18.8 | $559,577 | 102,529 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-12 Option Award | 2025-12-16 09:30 am | 2026-03-12 2035-12-12 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 1,198,000 | $0 | 2,498,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-30 7:28 pm | 2025-09-26 2035-06-26 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 800,000 | $0 | 800,000 (Direct) | View |
| 2024-05-24 Other | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 9:25 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 122,358 | $0 | 490,120 (Direct) | View |
| 2023-12-15 Option Award | 2023-12-19 5:28 pm | 2024-03-15 2033-12-15 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 183,881 | $0 | 183,881 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 5:10 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 527,211 | $0 | 850,728 (Direct) | View |
| 2021-07-08 Ownership(A) | 2023-02-06 5:39 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 777,934 (Direct) | View |
| 2021-07-08 Ownership | 2023-02-02 5:01 pm | N/A 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO | 351,985 | $0 | 552,934 (Direct) | View |
| 2022-12-16 Other | 2022-12-20 7:31 pm | N/A 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 300,000 | $0 | 0 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 5:34 pm | 2022-12-16 2032-12-16 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 323,517 | $0 | 323,517 (Direct) | View |
| 2022-06-30 Exercise | 2022-07-05 4:30 pm | 2012-07-10 2022-07-10 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $0 | 102,529 (Direct) | View |
| 2022-06-30 Exercise | 2022-07-05 4:30 pm | N/A N/A | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 29,767 | $16 | 102,529 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 6:45 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 951,821 | $0 | 1,443,994 (Direct) | View |
| 2021-12-17 Option Award | 2021-12-21 9:31 pm | 2022-03-17 2031-12-17 | RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer | 492,173 | $0 | 492,173 (Direct) | View |